DiviDrip · RARE

RARE — Ultragenyx Pharmaceutical Inc.

RARE is Ultragenyx Pharmaceutical Inc. (Healthcare) — a non-dividend-paying stock. Trading at $15.80. Market cap: $1.46B. Capital Quality Rank: 59/100 — Above average.

Stock snapshot

Price$15.80
Market cap$1.46B
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)59 / 100 · Above average
Revenue CAGR (3y)22.8%
Shareholder buyback yield-8.22%
Altman Z-score zoneDistress

About RARE

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Listed2014Employees1.4KHQNovato, CASectorHealthcareWebsiteultragenyx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside RARE. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is RARE's current stock price?

RARE (Ultragenyx Pharmaceutical Inc.) is currently trading at $15.80.

Does RARE pay a dividend?

RARE (Ultragenyx Pharmaceutical Inc.) does not currently pay a regular dividend.

What is RARE's Capital Quality Rank?

RARE has a Capital Quality Rank of 59/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track RARE in DiviDrip

Add RARE to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow